The uptake of meningococcus
B vaccines remains relatively slow, with GlaxoSmithKline's Bexsero being administered to more patients than Pfizer's Trumenba, especially by surveyed ID specialists.
Research suggests MenACWY induced a "robust immune response" against all four serogroups of Meningococcus
(Lalwani et al, 2015) and that five years after the vaccine was administered 79 per cent of cases still have immunity to C, W and Y serotypes (Baxter et al, 2015).
Contract notice: Public supply contract for the purchase and delivery of vaccines intended to protect children, adolescents and adults as if indication for primary immunization and the booster injection, against poliomyelitis, diphtheria, pertussis, tetanus, measles, rubella, mumps, chicken pox, hepatitis b, invasive disease haemophilus influenzae type b, meningococcus
c and the rotavirus.
The post mortem, which was completed late on Saturday, showed that the child died "of an infection that destroyed the adrenal glands, possibly meningococcus
The university system announced that, starting in 2017, it will require all students to receive vaccination against measles, mumps, rubella, chickenpox, meningococcus
, tetanus and whooping cough.
Humans are the only reservoir for meningococcus
, which usually colonizes the upper respiratory tract of [approximately equal to] 8%-25% of persons (1).
group B vaccine has been the first authorised vaccine targeting this disease, and 100 million doses have already been applied.
ABIVAX has signed an agreement with The Finlay Institute, Havana, Cuba, that will allow it to commercialize vaccines against typhoid, meningococcus
, and leptospirosis, in Asian and Latin American markets.
Vaccines are available in the United States for warding off four types of the meningococcus
6 The emergence of drug-resistant meningococcus
is increasingly worrisome.
Teenagers, people from manual work social classes and those who have recently had colds are also at higher risk of carrying the meningococcus
bug in their throats and noses, according to the research carried out at a Powys school.
VA-MENGOC-BC is the only vaccine available in the world against the disease caused by meningococcus
B and has been included since 1991 in Cuba's national infant immunization program.